C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2006
11/29/2006	CN1871215A Cyclic derivatives as modulators of chemokine receptor activity
11/29/2006	CN1871214A Process for the production of lactams
11/29/2006	CN1871213A Method for the continuous production of n-methyl-2-pyrrolidone (NMP)
11/29/2006	CN1871208A Aralkyl amines as cannabinoid receptor modulators
11/29/2006	CN1870990A Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2006	CN1287227C Electric photographic organic photoreceptor with charge transfer matter
11/29/2006	CN1286809C Arylphenyl-substituted cyclic ketoenols compound
11/29/2006	CN1286801C Dielectric substance with block effect preventing copper diffusion
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141679 Dehydrating N-(2-hydroxyethyl)-2-pyrrolidone (HEP) in presence of catalyst (cesium on silica) and added water; inhibition of N-ethyl-2-pyrrolidone by-product; crystallization-free
11/28/2006	US7141582 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders
11/23/2006	WO2006124494A1 TRANSITION-STATE INHIBITORS OF PIN1, α-KETOAMIDE-CONTAINING PEPTIDOMIMETICS, AND SYNTHESES THEREOF
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123762A1 Process for production of pyrrolidine compounds
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123356A1 Process for the preparation of indolone derivative
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123020A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	WO2006122408A1 Bir domain binding compounds
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	WO2005102997A8 3,4-disubstituted maleimides for use as vascular damaging agents
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264477 Methods of using cyclic amides
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264416 Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/23/2006	CA2609161A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	CA2606785A1 Fibroblast activation protein inhibitor compounds and methods
11/23/2006	CA2597791A1 Process for the preparation of indolone derivative
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724256A2 Novel process for the synthesis of 5-(4-fluorphenyl)-1-2(2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
11/22/2006	EP1723142A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1722781A2 Maleiimide anti-tumor phosphatase inhibitors
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1054906B1 Polymerization process with living characteristics and polymers made therefrom
11/22/2006	CN1867580A Compound modified with glycerol derivative
11/22/2006	CN1865245A 4,4'-dimaleimide-yl diphenyl ether preparation method
11/22/2006	CN1865244A Synthesis method of imide substituted bridge ring compound
11/22/2006	CN1865243A Production method of N-dodecyl pyrrolidone
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285597C 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
11/22/2006	CN1285593C Pyrrolopyridazine compound
11/22/2006	CN1285575C Heterocyclic thioesters and ketones
11/21/2006	US7138539 Colorant compounds containing copolymerizable vinyl groups
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138423 Diseases mediated by tachykinins and for seritonin reuptake transporter protein as reuptake inhibitors
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138386 Preventives or remedies for arthritis
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006014665A3 Arylpyrrolidine derivatives as nk-1/ssri antagonists
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258734 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analogues
11/16/2006	US20060258730 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060254772 High molecular weight polyamine salts as clay stabilizing agents
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof
11/15/2006	EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006	EP1720872A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720833A1 Method for purifying n-methyl-2-pyrrolidone
11/15/2006	EP1720832A1 Process for preparing n-protected 4-ketoproline derivatives
11/15/2006	EP1720825A1 New compounds, methods for their preparation and use thereof
11/15/2006	EP1720550A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1633703A4 Isotopically labeled chemically stable reagents and process for the synthesis thereof
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1235800B1 Process for the preparation of amorphous atorvastatin calcium
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006	CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006	CN1863769A Process for producing aminopyrrolidine derivative and intermediate compound
11/15/2006	CN1863768A 8-aza-11-deoxy prostaglandin analogues
11/15/2006	CN1862871A Electrolytic solution and battery
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/14/2006	US7135586 Biphenylcarboxamides useful as lipid lowering agents
11/14/2006	US7135585 Pyrrole derivatives, for controlling plant diseases caused by fungal plant pathogens
11/14/2006	US7135578 Antiarthritic agents
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118330A1 Composition of n-alkenyl carboxylic acid tertiary amide
11/09/2006	WO2006118319A1 Method for storing n-alkenyl carboxylic acid tertiary amide
11/09/2006	WO2006118307A1 Therapeutic agent for pain

1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 404